Rubicon Research Limited (NSE:RUBICON)
1,351.60
+7.20 (0.54%)
At close: Jun 16, 2026
Rubicon Research Market Cap
Rubicon Research has a market cap or net worth of 222.68 billion as of June 16, 2026.
Market Cap
222.68B
Enterprise Value
222.33B
Revenue
17.54B
Ranking
n/a
PE Ratio
88.28
Stock Price
1,351.60
Market Cap Chart
Since October 16, 2025, Rubicon Research's market cap has increased from 103.50B to 222.68B, an increase of 115.15%. That is a compound annual growth rate of 216.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 16, 2026 | 222.68B | 98.55% |
| Dec 31, 2025 | 112.15B | 8.37% |
| Oct 16, 2025 | 103.50B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Abbott India | 554.37B |
| GlaxoSmithKline Pharmaceuticals | 372.89B |
| J. B. Chemicals & Pharmaceuticals | 352.04B |
| AstraZeneca Pharma India | 212.49B |
| Granules India | 185.58B |
| Caplin Point Laboratories | 180.74B |
| Jubilant Pharmova | 155.48B |
| Viyash Scientific | 107.89B |